- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-50-0058811

Napre Pharma Private Limited
About Napre Pharma Private Limited
Data last updated:
Napre Pharma Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 10 August 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2022PTC168881.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Munesh Kumar and Yogesh Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 02 Semra Faizabad Road Chinhat, Lucknow, Uttar Pradesh, India – 226001.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.46 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹2,349 (net margin 0.5%) and EBITDA of ₹3,174 (EBITDA margin 0.7%).
Napre Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0058811).
Company details
Recognitions & Rankings of Napre Pharma
Contact details
Napre Pharma Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered AddressH. No. 02 Semra Faizabad Road Chinhat, Lucknow, Uttar Pradesh, India – 226001
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Napre Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Napre Pharma Private Limited, buy the company report.
Financials of Napre Pharma Private Limited
FY 2025 filings availableNapre Pharma Private Limited reported revenue of ₹4.46 Lakh (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year. EBITDA fell 54% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3,174 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2,349 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.7% | ||
| Net Profit Margin | 0.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Napre Pharma Private Limited, buy the company report.
Board of directors of Napre Pharma Private Limited
Napre Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munesh Kumar | Director | 10 Aug 2022 | 4 Years 2 Months | Current |
| Yogesh Singh | Director | 08 Dec 2022 | 3 Years 10 Months | Current |
Peer comparison
Napre Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Antlia Lab N Diagnostics Private Limited | ₹4.48 Lakh (FY 2022) | Delhi, India | ||||
| Bappa Aab Healthcare Private Limited | ₹4.48 Lakh (FY 2024) | 873.0% | Pune, Maharashtra, India | |||
| Amnivor Medicare Private Limited | ₹4.47 Lakh (FY 2024) | -78.0% | Marisdha, West Bengal, India | |||
| Obecity Management (India) Private Limited | ₹4.47 Lakh (FY 2025) | -16.0% | Chennai, Tamil Nadu, India | |||
| Comprehensive Hospital Solutions Private Limited | ₹4.47 Lakh (FY 2024) | 6.0% | Siliguri, West Bengal, India | |||
| Napre Pharma Private Limitedthis company | ₹4.46 Lakh (FY 2025) | ₹2,349 | 0.5% | -6.0% | Lucknow, Uttar Pradesh, India | |
| Zealorrent Healthcare Private Limited | ₹4.46 Lakh (FY 2024) | 39.0% | Delhi, India | |||
| Gloraximo Tradeline Private Limited | ₹4.44 Lakh (FY 2024) | -23.0% | Pune, Maharashtra, India | |||
| Hitows Healthcare Private Limited | ₹4.44 Lakh (FY 2025) | 35.0% | New Delhi, Delhi, India | |||
| Axiomway Wellness Private Limited | ₹4.43 Lakh (FY 2022) | Hooghly, West Bengal, India | ||||
| Amd Health Care Private Limited | ₹4.43 Lakh (FY 2022) | 29.0% | Patna, Bihar, India |
To see the full peer comparison of Napre Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Napre Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Napre Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Napre Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Napre Pharma Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Ashok Kumar ceased to be Director on 25 Jun 2024.
Frequently asked questions
Napre Pharma is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 10 August 2022 (4+ years old) and is registered under CIN U24290UP2022PTC168881.
Napre Pharma has 2 current directors:
- Munesh Kumar - Director
- Yogesh Singh - Director
The latest financial statements of Napre Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Napre Pharma is U24290UP2022PTC168881. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Napre Pharma was incorporated on 10 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Napre Pharma by revenue are Antlia Lab N Diagnostics Private Limited, Bappa Aab Healthcare Private Limited, Amnivor Medicare Private Limited, Obecity Management (India) Private Limited, Comprehensive Hospital Solutions Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Ashok Kumar ceased to be Director on 25 Jun 2024. Yogesh Singh was appointed as Director on 08 Dec 2022. Munesh Kumar was appointed as Director on 10 Aug 2022.
Yes, Napre Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0058811).
The registered office of Napre Pharma is at H. No. 02 Semra Faizabad Road Chinhat, Lucknow, Uttar Pradesh, India – 226001.
Napre Pharma operates in the chemicals industry, in the manufacturing segment.
Napre Pharma can be reached at its registered office: H. No. 02 Semra Faizabad Road Chinhat, Lucknow, Uttar Pradesh, India – 226001.

